| 000 | 03287nam a2200397 i 4500 | ||
|---|---|---|---|
| 999 |
_c393174 _d393174 _x1 |
||
| 001 | 393174 | ||
| 003 | ES-MaUEC | ||
| 005 | 20240314174339.0 | ||
| 006 | a|||| o|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100301s2008 xxu| o |||| 0|eng d | ||
| 020 | _a9781603270489 | ||
| 024 | 7 |
_a10.1007/978-1-60327-048-9 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRA1211 _b2008 EB |
|
| 245 | 0 | 0 |
_aEssential Concepts in Toxicogenomics _cedited by Donna L. Mendrick, William B. Mattes |
| 250 | _a1st edition 2008 | ||
| 264 | 1 |
_aTotowa, NJ _bHumana Press _c2008 |
|
| 300 | _a1 recurso en línea (XI, 277 páginas) | ||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 490 | 0 |
_aMethods in Molecular Biology _x1940-6029 _v460 |
|
| 505 | 0 | _aToxicogenomics and Classic Toxicology: How to Improve Prediction and Mechanistic Understanding of Human Toxicity -- Use of Traditional End Points and Gene Dysregulation to Understand Mechanisms of Toxicity: Toxicogenomics in Mechanistic Toxicology -- Quality Control of Microarray Assays for Toxicogenomic and In Vitro Diagnostic Applications -- Role of Statistics in Toxicogenomics -- Predictive Toxicogenomics in Preclinical Discovery -- In Vivo Predictive Toxicogenomics -- Bioinformatics: Databasing and Gene Annotation -- Microarray Probe Mapping and Annotation in Cross-Species Comparative Toxicogenomics -- Toxicogenomics in Biomarker Discovery -- From Pharmacogenomics to Translational Biomarkers -- Public Consortium Efforts in Toxicogenomics -- Applications of Toxicogenomics to Nonclinical Drug Development: Regulatory Science Considerations. | |
| 520 | _aThe field of toxicogenomics has been growing quickly, yet with rapid growth comes the need to periodically reflect on the nature of the field. Essential Concepts in Toxicogenomics collects reviews, opinion pieces and case studies from the leading experts in this dynamic field with a focus on its application to pharmaceuticals. Topics covered include issues that affect the quality of toxicogenomics experiments, statistical approaches to their data analysis, the use of such data to build toxicogenomic models, and the utilization of genomics to identify biomarkers within the preclinical and clinical arenas. Although not in the standard Methods in Molecular Biology™ series format, this volume retains the practicality and usefulness of the highly successful series. Informative and cutting-edge, Essential Concepts in Toxicogenomics is an ideal resource for pharmaceutical companies, chemical manufacturers, toxicologists, and all who must keep up-to-date on progress in this vital and important field. | ||
| 988 | _aSpringer_Protocols_2008 | ||
| 650 | 7 |
_2embne _9140328 _aToxicología |
|
| 650 | 7 |
_2embne _9164326 _aGenómica |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9781617376887 |
| 776 | 0 | 8 |
_iPrinted edition: _z9781588296382 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-60327-048-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b01/2024 _dz _eb _zSI |
||